The laser therapy devices market size is estimated to be valued at US$ 3 billion in 2023 and is expected to reach US$ 7 billion by 2033. The adoption of laser therapy devices is likely to advance at a CAGR of 8.8% during the forecast period.
Minimally invasive surgical procedures have entered the limelight within the global healthcare space. Incidences of surgical wounds and corresponding infections from conventional procedures have necessitated a shift towards alternative approaches. This has boded well for the laser therapy devices market.
Medical practitioners are exhibiting a high tilt towards low level laser therapy (LLLT), amid a growing perception of it improving patient outcomes and reducing incidences of laser surgery associated side-effects in the long-run. Moreover, maximum applications are expected in cancer treatment, addressing ophthalmic disorders and aesthetics medicine.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for laser therapy devices. The report tracks the global sales of laser therapy devices in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the healthcare industry in general, and laser surgery devices in particular.
| Attributes | Details |
|---|---|
| Estimated Market Size (2023) | US$ 3 billion |
| Projected Market Size (2033) | US$ 7 billion |
| CAGR through (2023 to 2033) | 8.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to FMI, the laser therapy devices market has been experiencing a substantial boost amid the increasing applicability rates across multiple therapeutic areas. However, maximum gains have been registered across the oncology, ophthalmology and aesthetic medicine domains. Regulatory authorities have been granting authorizations to various laser surgical alternatives.
In the short-run, the global laser therapy devices market is expected to post significant gains, reaching a valuation of nearly US$ 3 billion by 2023, expanding at a CAGR of 8.8%. Long-term prospects are also expected to remain largely positive, with manufacturers likely to introduce a slew of advanced laser therapy devices.
| Period | Market Size (in US$ billion) |
|---|---|
| 2018 | US$ 1 billion |
| 2022 | US$ 2 billion |
| 2023 | US$ 3 billion |
| 2033 | US$ 7 billion |
Surgical Evolution Unleashed: Riding the Minimally Invasive Wave to Soaring Growth
Globally, there has been an incline in the number of minimally invasive surgical procedures, mostly with the objective of reducing patient trauma. Minimally invasive surgeries require minimal incisions as deployment of advanced instruments permit surgeons to work without dissecting any body part. As minimally invasive techniques are continually sought for different pathologic processes, use of lasers is becoming highly popular in modern medicine.
Besides their practical usefulness in the operating room, lasers have a wide range of applications in ophthalmology, lithotripsy, oncology and dermatologic and cosmetic procedures. Laser lithotripsy has proven highly effective in the fragmentation of urinary and biliary stones.
Lasers can accomplish this by inducing a shockwave (photodermal effect). Likewise, in neurosurgery, laser interstitial thermal therapy (LITT) amongst patients who are not ideal surgical candidates.
Laser therapy is also being deployed for the ablation of conductive pathways. Today, the laser balloon catheter is a highly popular endoscopic ablation system (EAS) commonly used to treat atrial fibrillation.
The device consists of a catheter with a compliant balloon at its tip which is continuously flushed with deuterium oxide, and is inserted into the left atrium. Such extensive applications are providing numerous laser therapy device manufacturers to increase their presence across key regions.
According to the Cancer Atlas, there were an estimated 18.1 million active cases, with over 9 million cancer deaths in 2018. Nearly 44 million individuals persons living with cancer that same year who were diagnosed within the previous’ five years. It is projected that this burden is expected to rise by over 60% by 2040.
Hence, healthcare providers are introducing highly advanced therapeutics. Host non-invasive procedures have been developed in recent years, including laser therapy, which have proven highly effective in reducing the incidence. Lasers can be used in two main ways: to shrink or destroy a tumor with heat or to activate a chemical (also known as a photosensitizing agent), which kills only cancer cells.
Though lasers can be used alone, they are often used with other cancer treatments, such as chemotherapy or radiation therapy. Such heightened applications are opening up doors for numerous manufacturers. Prominent oncology grade laser systems players include BIOSPEC (Russia), Lynton Lasers Ltd. (England), Modulight USA Inc. and Pioneer Optics Co. (USA) among others.
Principal Consultant
As people become increasingly conscious about their appearance, investments in aesthetic surgeries to keep their bodies in shape are increasing. According to the American Society for Aesthetic Plastic Surgery (ASAPS), between 2012 and 2017, the top 5 cosmetic procedures include breast augmentation procedures (4.1%); liposuction (58%), eyelid surgery (33.5%), breast lift (57.5%) and tummy tuck (27.8%). As of 2017, Americans spent over US$ 6 billion on surgical cosmetic procedures.
A majority of the aforementioned surgical procedures have now shifted toward laser therapeutics, with maximum emphasis on improving safety and efficacy of such procedures. Prominent manufacturers’ primary emphasis is on laser device innovations. For instance, Cutera’s Dermastat handpiece has helped improve it’s excel® V+ device outcomes, which deploys laser technology to treat vascular and pigmented lesions.
The device’s power has been increased to accommodate a larger spot size, and is equipped with thicker cooling windows, rendering it more comfortable and safer. Similarly, Lutronic’s 1927 mm thulium laser lase MD deploys a CO2 or erbium YAG (er:YAG) laser which helps in effective skin resurfacing.
Burns, scarring, dyspigmentation, ocular injury and infection are highly commonplace in the aftermath of several laser therapies. Amongst these, infections are of the utmost concern as they can disrupt the barrier function of the skin, particularly after ablative procedures. Cutaneous infections can present atypically after ablative resurfacing.
Herpes simplex virus (HSV) reactivation is commonly seen after laser treatments, particularly in the perioral skin. Attributed to such incidences, patients are apprehensive about undergoing advanced laser surgeries, which is anticipated to limit sales of laser therapy devices to a significant extent.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In recent years, the United States has experienced a major uptick in the number of laser surgical procedures, most notably in ophthalmology. According to estimates published by QualSight, the number of LASIK vision correction procedures in the United States through 2019 reached 23 million, with myopia surgeries comprising the bulk of all surgeries.
It is projected that over 30 million Americans suffer from myopia, while the next major condition is cataract, affecting over 24 million people over the age of 40. This high incidence is opening up opportunistic prospects for cold laser therapy device manufacturers across the region, also known as low-level laser therapy (LLLT) or photodynamic therapy (PDT).
Besides these common ailments, cold laser therapy is also used to treat wet macular degeneration and central serous chorioretinopathy. The treatment is being extrapolated to numerous other ailments, including musculoskeletal pain treatment. Genesis Medical is a pioneer in offering cold laser therapy skin treatments across the United States, offering ultherapy, titan laser treatment, limelight laser (IPL) and laser vein removal among others.
The United Kingdom market is poised to open up significant growth frontiers, as healthcare providers make efforts to bolster LLLT approaches. Recently, in March 2021, B-Cure Laser, a popular handheld LLLT device, made its debut across the landscape. With over 28 million chronic pain patients, the device is likely to find popularity as an effective at-home, alternative treatment option.
According to a popular study, incidence of chronic pain across the United Kingdom increases with age, affected up to 62% of the population aged 75 and above. Nearly 8 million people are moderately or severely limited by the pain. In addition, laser therapy is also deployed to treat soft tissue and sports injuries such as muscle and ligament strains.
Omega Laser Systems is a prominent face in the United Kingdom laser therapy systems market. The company offers LLLT to reduce pain induced by rheumatoid arthritis. After a series of 82 laboratory trials and 11 randomized clinical trials. 87% of them yield positive results. Hence, the solution has been widely approved for treatment across the country. It also offers treatment for wound healing procedures.
According to a National Center for Biotechnology Information study, there is a very high prevalence rate of dermatological disorders throughout Germany. The study, which was conducted in 2008, included a sample size of more than 48,000 persons, with a mean age of 43.2 years.
End-results revealed the following prevalence rates: 8.9% contact eczema, 4.2% acne, 3.4% seborrheic eczema, 2.2% rosacea, 2.1% psoriasis vulgaris, 1.4% atopic eczema and 0.07% lichen ruber. In total, dermatological findings needing treatment were observed in 19% of the study cohort; 1.3% of the participants presented a suspicious finding requiring diagnostics for skin malignoma.
Consequently, healthcare providers have been incorporating laser therapy treatment approaches to eradicate this burden. Hautmedizin Bad Soden is one of the frontrunners in the German laser therapy which offers treatment for dermatological and aesthetic purposes. It employs the erbium: YG laser, the ablative CO2 laser, fractionated CO2 laser and yellow laser amongst other approaches.
The laser therapy devices market is anticipated to perform significantly well across France, mostly attributed to the country’s superior position in the global healthcare industry. Owing to the scope for conducting excellent scientific and clinical research, prominent manufacturers are expected to intensify their presence across the region.
The National Institute for Health and Medical Research and the National Center for Scientific Research are two major organizations which are assisting in strengthening the French healthcare industry by providing numerous grants for funding clinical studies to verify the efficacy of multiple surgical approaches to various ailments. Moreover, in 2018, the French Investment Bank created a €200 million fund entirely dedicated to healthcare startups.
Owing to these developments forays into laser therapy devices and laser treatment is accelerating at an impressive pace. Promises are especially bright across the aesthetics domain, with players such as ADSS Beauty Equipment, Quantel Medical and LSO Medical having a robust presence throughout the country.
China is likely to post lucrative gains with respect to laser therapy devices throughout the Asia-Pacific, particularly across medical aesthetics. As disposable incomes rise, people experience a higher standard of living, motivating them to spend more on cosmetically enhancing surgeries, providing a wide platform for the introduction of various therapeutic approaches.
According to statistic from the Health Commission, the total revenue of the domestic aesthetic medicine service market is poised to reach US$ 55.4 billion in 2023. Likewise, major Chinese pharmaceutical companies are also augmenting investments in the aesthetics medicine domain. All these factors are expected to widen laser therapy devices sales across the East Asian giant.
Presently, micro-cosmetics are the core focus of Chinese medical aesthetics, generating three-fifths of the total income. By 2019, more than seven out of ten aesthetic procedures involved non-surgical ones. Moreover, more than half of all cases are likely to involve plastic surgery amongst the younger population.
By device type, gas laser therapy products are anticipated to generate substantial demand, attributed to its extensive applications across ENT, gynecology, plastic and maxillofacial surgery, and urology. The most common type is the argon laser, mostly at wavelengths ranging between 488 and 514 nm.
Argon lasers are highly effective in coagulating blood vessels, and can be used in microsurgeries on the ear, bleeding ulcers of the stomach and duodenum, and the removal of vascular lesions or polyps. It is also effective in removing small skin tumors, both benign and malignant.
As per FMI’s analysis, hospital-grade laser therapy devices will experience considerable momentum, registering a CAGR exceeding 4% in the short-run, likely to be valued at over US$ 400 million. Demand is likely to be strong amid increasing hospitalization rates for key surgical procedures in the urology, dermatology and cardiovascular domains.
However, demand is expected to stay strong amongst the specialty clinics segment, projected to generate over half of the total revenue share. Increasing preference by patients to visit specialized centers for specific ailments is projected to increase adoption of laser therapy devices across specialty clinics.
Based on application, the ophthalmology segment is expected to be the major beneficiary of laser therapy devices. It is likely to surpass a value of US$ 500 million until 2022. Increasing number of ophthalmic procedures to treat such disorders as glaucoma, cataract and retinopathy are widening adoption of laser surgeries, thus stimulating growth.
Prominent manufacturers such as Carl Zeiss AG are at the forefront of ophthalmic laser therapy devices manufacturing. The company offers a wide range of photocoagulation lasers, photodisruption lasers and combi-lasers for posterior and anterior treatment. Likewise, Johnson & Johnson’s CATALYSTM precision laser system provides a 3D OCT imaging technology to facilitate accurate laser incisions.
The competitive landscape of the Laser Therapy Devices market is dynamic and rapidly evolving. Numerous established players dominate the market, including companies like Lumenis Ltd., and Thermo Fisher Scientific Inc. These companies have a strong presence in the market and offer a wide range of laser therapy devices for various medical and cosmetic applications. There is a growing influx of new entrants and startups, bringing innovation and technological advancements to the market. These players often focus on niche applications or introduce disruptive technologies to gain a competitive edge. To maintain their position, established players strive to enhance product portfolios, invest in R&D, and forge strategic partnerships to expand their market reach and stay ahead of emerging competitors.
Strategies for Laser Therapy Devices Manufacturers to Expand in the Market
Product Portfolio:
| Attributes | Details |
|---|---|
| Market Value in 2023 | US$ 3 billion |
| Market Value in 2033 | US$ 7 billion |
| Growth Rate | CAGR of 7% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ billion and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization & Pricing | Available Upon Request |
The laser therapy devices market is slated to attain US$ 3 billion in 2023.
The future growth rate of laser therapy devices market is 8.8% CAGR.
Integration of AR and VR technologies for better patient experience is a major trend in the market.
Exploration of laser therapy potential in regenerative medicine is creating new opportunities in the market.
The top 5 companies in the market are Lumenis Ltd., Coherent Inc., and Biolitec AG.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Device Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Device Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Device Type, 2023 to 2033
5.3.1. Solid-State Laser
5.3.2. Gas Laser
5.3.3. Liquid Laser
5.3.4. Semiconductor Laser
5.4. Y-o-Y Growth Trend Analysis By Device Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Device Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-User, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-User, 2023 to 2033
6.3.1. Hospitals
6.3.2. Specialized Clinics
6.3.3. Ambulatory Surgical Centers
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033
7.3.1. Ophthalmology
7.3.2. Dermatology
7.3.3. Gynecology
7.3.4. Urology
7.3.5. Cardiovascular
7.3.6. Others
7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. The USA
9.2.1.2. Canada
9.2.2. By Device Type
9.2.3. By End-User
9.2.4. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Device Type
9.3.3. By End-User
9.3.4. By Application
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Device Type
10.2.3. By End-User
10.2.4. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Device Type
10.3.3. By End-User
10.3.4. By Application
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Device Type
11.2.3. By End-User
11.2.4. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Device Type
11.3.3. By End-User
11.3.4. By Application
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Singapore
12.2.1.5. Thailand
12.2.1.6. Indonesia
12.2.1.7. Australia
12.2.1.8. New Zealand
12.2.1.9. Rest of Asia Pacific
12.2.2. By Device Type
12.2.3. By End-User
12.2.4. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Device Type
12.3.3. By End-User
12.3.4. By Application
12.4. Key Takeaways
13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Device Type
13.2.3. By End-User
13.2.4. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Device Type
13.3.3. By End-User
13.3.4. By Application
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By Device Type
14.1.2.2. By End-User
14.1.2.3. By Application
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By Device Type
14.2.2.2. By End-User
14.2.2.3. By Application
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By Device Type
14.3.2.2. By End-User
14.3.2.3. By Application
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By Device Type
14.4.2.2. By End-User
14.4.2.3. By Application
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By Device Type
14.5.2.2. By End-User
14.5.2.3. By Application
14.6. United Kingdom
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By Device Type
14.6.2.2. By End-User
14.6.2.3. By Application
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By Device Type
14.7.2.2. By End-User
14.7.2.3. By Application
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By Device Type
14.8.2.2. By End-User
14.8.2.3. By Application
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By Device Type
14.9.2.2. By End-User
14.9.2.3. By Application
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By Device Type
14.10.2.2. By End-User
14.10.2.3. By Application
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By Device Type
14.11.2.2. By End-User
14.11.2.3. By Application
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By Device Type
14.12.2.2. By End-User
14.12.2.3. By Application
14.13. Singapore
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By Device Type
14.13.2.2. By End-User
14.13.2.3. By Application
14.14. Thailand
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By Device Type
14.14.2.2. By End-User
14.14.2.3. By Application
14.15. Indonesia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By Device Type
14.15.2.2. By End-User
14.15.2.3. By Application
14.16. Australia
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2022
14.16.2.1. By Device Type
14.16.2.2. By End-User
14.16.2.3. By Application
14.17. New Zealand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2022
14.17.2.1. By Device Type
14.17.2.2. By End-User
14.17.2.3. By Application
14.18. GCC Countries
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2022
14.18.2.1. By Device Type
14.18.2.2. By End-User
14.18.2.3. By Application
14.19. South Africa
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2022
14.19.2.1. By Device Type
14.19.2.2. By End-User
14.19.2.3. By Application
14.20. Israel
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2022
14.20.2.1. By Device Type
14.20.2.2. By End-User
14.20.2.3. By Application
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Device Type
15.3.3. By End-User
15.3.4. By Application
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Boston Scientific Corporation
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. IPG Photonics Corporation
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Lumenis Ltd.
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Coherent Inc.
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Biolitec AG
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. Hologic Inc.
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. Alma Lasers Ltd.
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. Fotona D.D
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
16.1.9. Danaher Corporation
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.9.5.2. Product Strategy
16.1.9.5.3. Channel Strategy
16.1.10. Thermo Fisher Scientific Inc.
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.10.5.2. Product Strategy
16.1.10.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports
Laser Therapy Devices Market
